These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 22894624
1. A new pure ω-3 eicosapentaenoic acid ethyl ester (AMR101) for the management of hypertriglyceridemia: the MARINE trial. Jacobson TA. Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):687-95. PubMed ID: 22894624 [Abstract] [Full Text] [Related]
2. Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial). Bays HE, Ballantyne CM, Kastelein JJ, Isaacsohn JL, Braeckman RA, Soni PN. Am J Cardiol; 2011 Sep 01; 108(5):682-90. PubMed ID: 21683321 [Abstract] [Full Text] [Related]
4. Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study). Bays HE, Braeckman RA, Ballantyne CM, Kastelein JJ, Otvos JD, Stirtan WG, Soni PN. J Clin Lipidol; 2012 Sep 01; 6(6):565-72. PubMed ID: 23312052 [Abstract] [Full Text] [Related]
5. Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials). Mosca L, Ballantyne CM, Bays HE, Guyton JR, Philip S, Doyle RT, Juliano RA. Am J Cardiol; 2017 Feb 01; 119(3):397-403. PubMed ID: 27939227 [Abstract] [Full Text] [Related]
20. Icosapent ethyl therapy for very high triglyceride levels: a 12-week, multi-center, placebo-controlled, randomized, double-blinded, phase III clinical trial in China. Wang Z, Zhang X, Qu Y, Zhang S, Chen Y, Chen X, Qi X, Liu P, Liu S, Jiang S, Man R, He L, Wu L, Li Z, Shang Y, Qiu Z, Liu F, Xu C, Lai C, Ge J. Lipids Health Dis; 2023 Jun 10; 22(1):71. PubMed ID: 37301827 [Abstract] [Full Text] [Related] Page: [Next] [New Search]